
Pentaglobe Pharmacy Private Limited
About Pentaglobe Pharmacy Private Limited
Data last updated:
Pentaglobe Pharmacy Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PTC364650. Its GSTIN is 07AALCP1752C1ZL (Delhi).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹47.01 Lakh. It is led by directors Damanpreet Singh and Upinder Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shop No – 10 Lsc Market Block A Preet Vihar, Delhi, India – 110092.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.21 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹61,786 (net margin 0.5%) and EBITDA of ₹1.68 Lakh (EBITDA margin 1.4%).
Company details
Recognitions & Rankings of Pentaglobe Pharmacy
Contact details
Pentaglobe Pharmacy Private Limited's registered office is in Delhi, Delhi.
- Registered AddressShop No – 10 Lsc Market Block A Preet Vihar, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pentaglobe Pharmacy is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Pentaglobe Pharmacy Private Limited, buy the company report.
Financials of Pentaglobe Pharmacy Private Limited
FY 2023 filings availablePentaglobe Pharmacy Private Limited reported revenue of ₹1.21 Cr (up 14% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 14% in the latest year. EBITDA rose 27% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.68 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹61,786 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.4% | ||
| Net Profit Margin | 0.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Pentaglobe Pharmacy Private Limited, buy the company report.
Board of directors of Pentaglobe Pharmacy Private Limited
Pentaglobe Pharmacy has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Damanpreet Singh Also directs: Kidlac Products Limited, FSV Foods Private Limited, Abhanjj Industries Private Limited and 5 more | Director | 02 May 2022 | 4 Years 6 Months | Current |
| Upinder Singh Also directs: Kidlac Products Limited, FSV Foods Private Limited, Abaran Industries Private Limited and 5 more | Director | 02 May 2022 | 4 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Pentaglobe Pharmacy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pentaglobe Pharmacy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pentaglobe Pharmacy has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCP1752C1ZL | Delhi | Active | 15 Jul 2020 |
To see the full GST registrations and return filing status of Pentaglobe Pharmacy Private Limited, buy the company report.
Recent activity
Pentaglobe Pharmacy Private Limited has 10 board changes on record since 2020: 6 appointments and 4 cessations. The latest: Ashok Kumar Jain ceased to be Additional Director on 03 May 2022.
1 earlier event is in the company report.
Frequently asked questions
Pentaglobe Pharmacy is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 June 2020 (6+ years old) and is registered under CIN U24304DL2020PTC364650.
Pentaglobe Pharmacy has 2 current directors:
- Damanpreet Singh - Director
- Upinder Singh - Director
The latest financial statements of Pentaglobe Pharmacy on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Pentaglobe Pharmacy is 07AALCP1752C1ZL, registered in Delhi.
The CIN (Corporate Identification Number) of Pentaglobe Pharmacy is U24304DL2020PTC364650. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pentaglobe Pharmacy was incorporated on 10 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Ashok Kumar Jain ceased to be Additional Director on 03 May 2022. Nitesh Kumar ceased to be Additional Director on 03 May 2022. Damanpreet Singh was appointed as Director on 02 May 2022. Pentaglobe Pharmacy has 10 board changes on record in total.
Yes, Pentaglobe Pharmacy is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Pentaglobe Pharmacy is at Shop No – 10 Lsc Market Block A Preet Vihar, Delhi, India – 110092.
Pentaglobe Pharmacy operates in the pharma industry, in the drug formulation and development segment.

